$3.03
Rani Therapeutics Holdings is a biotechnology business based in the US. Rani Therapeutics Holdings shares (RANI) are listed on the NASDAQ and all prices are listed in US Dollars. Rani Therapeutics Holdings employs 140 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Rani Therapeutics stock
How to buy Rani Therapeutics Holdings stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – RANI. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Rani Therapeutics Holdings stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Rani Therapeutics Holdings stock price (NASDAQ: RANI)
Use our graph to track the performance of RANI stocks over time.Rani Therapeutics Holdings shares at a glance
Latest market close | $3.03 |
---|---|
52-week range | $1.82 - $8.75 |
50-day moving average | $4.30 |
200-day moving average | $3.72 |
Wall St. target price | $11.13 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-1.29 |
Is it a good time to buy Rani Therapeutics Holdings stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Rani Therapeutics Holdings price performance over time
Historical closes compared with the close of $3.03 from 2024-07-23
1 week (2024-07-17) | -18.11% |
---|---|
1 month (2024-06-24) | -26.28% |
3 months (2024-04-24) | -56.65% |
6 months (2024-01-24) | -20.05% |
1 year (2023-07-24) | -25.92% |
---|---|
2 years (2022-07-22) | -74.77% |
3 years (2021-07-20) | N/A |
5 years (2019-07-20) | N/A |
Rani Therapeutics Holdings financials
Gross profit TTM | $2.7 million |
---|---|
Return on assets TTM | -53.03% |
Return on equity TTM | -172.96% |
Profit margin | 0% |
Book value | $0.28 |
Market Capitalization | $159.2 million |
TTM: trailing 12 months
Rani Therapeutics Holdings share dividends
We're not expecting Rani Therapeutics Holdings to pay a dividend over the next 12 months.
Rani Therapeutics Holdings share price volatility
Over the last 12 months, Rani Therapeutics Holdings's shares have ranged in value from as little as $1.82 up to $8.75. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Rani Therapeutics Holdings's is 0.16. This would suggest that Rani Therapeutics Holdings's shares are less volatile than average (for this exchange).
To put Rani Therapeutics Holdings's beta into context you can compare it against those of similar companies.
- Oramed Pharmaceuticals (ORMP.US): 1.784
- Athersys (ATHX.US): -0.901
- Arbutus Biopharma (ABUS.US): 1.957
Rani Therapeutics Holdings overview
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co. , Ltd. for the o-development and commercialization of RT-114 to treat obesity.
Frequently asked questions
What percentage of Rani Therapeutics Holdings is owned by insiders or institutions?Currently 48.88% of Rani Therapeutics Holdings shares are held by insiders and 13.966% by institutions. How many people work for Rani Therapeutics Holdings?
Latest data suggests 140 work at Rani Therapeutics Holdings. When does the fiscal year end for Rani Therapeutics Holdings?
Rani Therapeutics Holdings's fiscal year ends in December. Where is Rani Therapeutics Holdings based?
Rani Therapeutics Holdings's address is: 2051 Ringwood Avenue, San Jose, CA, United States, 95131 What is Rani Therapeutics Holdings's ISIN number?
Rani Therapeutics Holdings's international securities identification number is: US7530181004
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question